B47.1 Actinomycetoma

Name of the Condition

• Actinomycetoma

Summary

Actinomycetoma is a chronic, progressive subcutaneous infection characterized by granulomatous tissue formation and sinus tract development. It is caused by actinomycetes bacteria and primarily affects the extremities, particularly the feet. The condition is endemic in tropical and subtropical regions and may lead to significant morbidity if untreated, including tissue destruction and deformity.

Causes

Actinomycetoma is caused by actinomycetes bacteria, including species such as Nocardia, Actinomadura, or Streptomyces. Infection occurs through traumatic inoculation of the organism into the skin, often via thorns, splinters, or other penetrating injuries, leading to localized tissue invasion and chronic inflammation. The bacteria thrive in soil and organic matter, facilitating exposure in endemic areas.

Risk Factors

• Residence in or travel to endemic regions (e.g., parts of Africa, Asia, and Latin America).
• Occupational exposure to soil or organic matter, such as farming or walking barefoot.
• Traumatic skin injuries in contaminated environments.
• Immunocompromised states, including HIV/AIDS or diabetes, which may increase susceptibility to severe disease.

Symptoms

• Painless or mildly painful subcutaneous swelling, often on the foot or hand.
• Formation of sinus tracts draining serous or purulent fluid, sometimes containing bacterial grains.
• Progressive tissue destruction and deformity over time.
• Limited range of motion in affected extremities.

Diagnosis

Diagnosis involves clinical evaluation, including the presence of characteristic sinus tracts and grains. Microscopic examination of drained fluid or tissue samples may reveal bacterial grains. Culture and histopathological analysis help identify the causative organism. Imaging studies, such as X-rays or MRI, assess the extent of tissue involvement and bone destruction.

Treatment Options

Treatment typically includes long-term antibiotic therapy, often with a combination of medications like sulfonamides, aminoglycosides, or tetracyclines, tailored to the specific bacterial species. Surgical intervention may be necessary to remove necrotic tissue or address severe deformity. Treatment duration is prolonged, often lasting several months to years, and requires close monitoring for response.

Prognosis and Follow-Up

With early and appropriate treatment, prognosis is generally favorable, though recovery may be slow. Untreated or delayed treatment can lead to permanent tissue damage, deformity, or disability. Regular follow-up is essential to monitor treatment response, manage complications, and adjust therapy as needed.

Complications

• Chronic pain and functional impairment.
• Extensive tissue destruction and deformity.
• Secondary bacterial infections.
• Spread of infection to deeper structures, including bones.

Lifestyle & Prevention

• Avoid walking barefoot in endemic areas to reduce exposure to soil-borne bacteria.
• Wear protective footwear and clothing when working in environments with thorns or splinters.
• Promptly clean and treat any traumatic skin injuries to minimize infection risk.
• Maintain good overall health to support immune function.

When to Seek Professional Help

Seek medical attention if you experience persistent swelling, sinus tract formation, or drainage from a skin injury, especially after exposure to soil or organic matter in endemic regions. Early evaluation is critical to prevent progression and complications.

Tips for Medical Coders

When coding for actinomycetoma, use ICD-10-CM code B47.1. Ensure documentation supports the diagnosis, including clinical findings (e.g., sinus tracts, grains), causative organism identification, and treatment details. Note the chronic nature of the condition and any associated complications for accurate code assignment.